Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission.
作者信息
Gorin Norbert-Claude, Labopin Myriam, Meloni Giovanna, Pigneux Arnaud, Esteve Jordi, Mohamad Mohty
机构信息
Hôpital Saint Antoine, Department of Hematology, Paris, France.
出版信息
Haematologica. 2013 Feb;98(2):e12-4. doi: 10.3324/haematol.2012.064436. Epub 2012 Aug 28.
Abstract
摘要
相似文献
1
Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission.FLT3内部串联重复/核仁磷酸蛋白1（NPM1）突变状态对首次缓解期接受自体造血干细胞移植的成年急性髓细胞白血病患者的影响。
Haematologica. 2013 Feb;98(2):e12-4. doi: 10.3324/haematol.2012.064436. Epub 2012 Aug 28.
2
Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission.在首次完全缓解时接受自体造血干细胞移植的急性髓系白血病患者中使用FLT3和NPM1进行风险分层。
Bone Marrow Transplant. 2020 Dec;55(12):2244-2253. doi: 10.1038/s41409-020-0936-z. Epub 2020 May 10.
3
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.异基因干细胞移植可提高具有高突变型FLT3-ITD等位基因比例特征的急性髓系白血病患者的生存率。
Biol Blood Marrow Transplant. 2016 Mar;22(3):462-9. doi: 10.1016/j.bbmt.2015.10.023. Epub 2015 Nov 10.
4
The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.无 FLT3-ITD、NPM1 和双等位 CEBPA 突变的中危急性髓系白血病微小残留病检测对预后和缓解后治疗选择的影响。
Hematology. 2021 Dec;26(1):179-185. doi: 10.1080/16078454.2021.1880753.
5
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.细胞遗传学正常的急性髓系白血病中的突变与治疗结果
N Engl J Med. 2008 May 1;358(18):1909-18. doi: 10.1056/NEJMoa074306.
6
Acute myeloid leukemia in patients older than 75: prognostic impact of FLT3-ITD and NPM1 mutations.75岁以上患者的急性髓系白血病：FLT3-ITD和NPM1突变的预后影响
Leuk Lymphoma. 2015 Jan;56(1):147-50. doi: 10.3109/10428194.2014.913288. Epub 2014 Jun 16.
7
Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.CEBPA 突变对年轻急性髓系白血病患者大队列的预后意义：双 CEBPA 突变的影响以及与 FLT3 和 NPM1 突变的相互作用。
J Clin Oncol. 2010 Jun 1;28(16):2739-47. doi: 10.1200/JCO.2009.26.2501. Epub 2010 May 3.
8
Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.60岁以上急性髓系白血病患者中核磷蛋白突变和Flt3内部串联重复的临床影响
Eur J Haematol. 2008 Mar;80(3):208-15. doi: 10.1111/j.1600-0609.2007.01019.x.
9
Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy.伴有低等位基因负担 FLT3-ITD 突变和同时性 NPM1 突变的急性髓系白血病患者的有利结局：与缓解后治疗相关。
Blood. 2013 Apr 4;121(14):2734-8. doi: 10.1182/blood-2012-06-431122. Epub 2013 Feb 1.
10
Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.NPM1突变和FLT3内部串联重复在埃及细胞遗传学正常的急性髓系白血病患者中的预后意义
Hematology. 2014 Jan;19(1):22-30. doi: 10.1179/1607845413Y.0000000085. Epub 2013 Nov 25.
引用本文的文献
1
The Clinicopathological Impact of Granulocyte-Macrophage Colony-Stimulating Factor Gene Expression and Different Molecular Prognostic Biomarkers in Egyptian Acute Myeloid Leukemia Patients.埃及急性髓系白血病患者粒细胞-巨噬细胞集落刺激因子基因表达与不同分子预后生物标志物的临床病理影响。
Asian Pac J Cancer Prev. 2020 Jul 1;21(7):1993-2001. doi: 10.31557/APJCP.2020.21.7.1993.
2
Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission.在首次完全缓解时接受自体造血干细胞移植的急性髓系白血病患者中使用FLT3和NPM1进行风险分层。
Bone Marrow Transplant. 2020 Dec;55(12):2244-2253. doi: 10.1038/s41409-020-0936-z. Epub 2020 May 10.
3
Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis.光动力金属配合物通过生长抑素受体介导靶向急性髓细胞白血病诱导光凋亡。
Sci Rep. 2020 Jan 15;10(1):371. doi: 10.1038/s41598-019-57172-6.
4
[Advances in autologous stem cell transplantation for acute myeloid leukemia].[急性髓系白血病自体干细胞移植的进展]
Zhonghua Xue Ye Xue Za Zhi. 2019 Mar 14;40(3):247-251. doi: 10.3760/cma.j.issn.0253-2727.2019.03.018.
5
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission.自体干细胞移植对于低危和中危急性髓系白血病（AML）患者而言仍是一种有效的选择：一项针对809例首次完全缓解后接受自体移植患者的GITMO调查。
Bone Marrow Transplant. 2017 Jan;52(1):163-166. doi: 10.1038/bmt.2016.233. Epub 2016 Sep 26.
6
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT.与自体干细胞移植相比，匹配和不匹配的无关供体用于首次完全缓解期急性髓系白血病的移植：欧洲血液与骨髓移植协会急性白血病工作组的一项回顾性、倾向评分加权分析
J Hematol Oncol. 2016 Sep 2;9(1):79. doi: 10.1186/s13045-016-0314-x.
7
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.静脉注射白消安用于成年急性髓系白血病患者自体干细胞移植：代表欧洲血液与骨髓移植组急性白血病工作组对952例患者的调查
Haematologica. 2014 Aug;99(8):1380-6. doi: 10.3324/haematol.2014.105197. Epub 2014 May 9.
本文引用的文献
1
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation in adults with acute myeloid leukemia.成人急性髓系白血病的低强度预处理异基因造血细胞移植。
Cancer Control. 2011 Oct;18(4):237-45. doi: 10.1177/107327481101800404.
2
Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group.NPM1 突变型急性髓系白血病微小残留病监测：德国-奥地利急性髓系白血病研究组的一项研究。
J Clin Oncol. 2011 Jul 1;29(19):2709-16. doi: 10.1200/JCO.2011.35.0371. Epub 2011 May 9.
3
Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia.NPM1 突变型急性髓系白血病中 FLT3-ITD 负荷的预后影响。
Leukemia. 2011 Aug;25(8):1297-304. doi: 10.1038/leu.2011.97. Epub 2011 May 3.
4
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?伴有核仁磷酸蛋白（NPM1）突变的急性髓系白血病：它是一个独特的实体吗？
Blood. 2011 Jan 27;117(4):1109-20. doi: 10.1182/blood-2010-08-299990. Epub 2010 Oct 28.
5
Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.造血细胞移植后慢性健康状况的患病率及其预测因素：来自骨髓移植幸存者研究的报告。
Blood. 2010 Oct 28;116(17):3129-39; quiz 3377. doi: 10.1182/blood-2009-06-229369. Epub 2010 Jul 23.
6
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission.在第一次缓解期时，自体外周血造血干细胞移植中输注更高剂量 CD34+细胞的急性髓细胞性白血病患者，其复发率更高。
Blood. 2010 Oct 28;116(17):3157-62. doi: 10.1182/blood-2009-11-252197. Epub 2010 May 17.
7
Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.经大剂量连续输注伊达比星和白消安预处理后，伴有核仁磷酸蛋白基因突变的急性髓细胞白血病患者进行自体移植后获得良好结果。
Biol Blood Marrow Transplant. 2010 Jul;16(7):1018-24. doi: 10.1016/j.bbmt.2010.02.011. Epub 2010 Feb 19.
8
Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.欧洲血液与骨髓移植合作组的一项回顾性研究：急性髓细胞白血病伴16号染色体倒位或t(8;21)首次缓解期患者自体或基因相同的异基因造血干细胞移植后的相同结局
J Clin Oncol. 2008 Jul 1;26(19):3183-8. doi: 10.1200/JCO.2007.15.3106. Epub 2008 May 27.
9
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.细胞遗传学正常的急性髓系白血病中的突变与治疗结果
N Engl J Med. 2008 May 1;358(18):1909-18. doi: 10.1056/NEJMoa074306.
10
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).1485例成年急性髓系白血病（AML）患者中NPM1突变的发生率及预后影响
Blood. 2006 May 15;107(10):4011-20. doi: 10.1182/blood-2005-08-3167. Epub 2006 Feb 2.
Zotero 插件